Sept 6 (Reuters) - Allergan Plc :
* Allergan Acquires Gene Therapy Company Retrosense Therapeutics Adding First-In-Class technology to company’s innovative eye care pipeline
* Says under terms of transaction, Allergan has paid Retrosense a $60 million upfront payment
* Says also has agreed to potential regulatory and commercialization milestone payments related to rst-001
* Says acquired substantially all of assets of Retrosense in an all-cash transaction Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.